CortiSlim warning letter
This article was originally published in The Tan Sheet
Executive Summary
Promotional materials for CortiSlim dietary supplement feature claims that cause the product to be misbranded under the FD&C Act, FDA tells Window Rock Enterprises in an Aug. 19 warning letter. Claims such as "Controls cortisol levels within a healthy range" on the product label, brochure, start guide and website "are not supported by reliable scientific evidence" and therefore are false and misleading, the agency says. Window Rock had 15 days to respond with appropriate measures...